Deborah Boldt-Houle, PhD

Tolmar, Inc.
Buffalo Grove, United States

Disclosure information not submitted.

Presentation(s):

• SAT-228 - Long-Term Real-World Evidence of Clinical Suppression with 6-Month Subcutaneous Leuprolide Acetate in Children with Central Precocious Puberty

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SUN-133 - A Multivariable Dose-Selection Predictor to Optimize JATENZO® Dose Titration in Hypogonadal Men

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT